Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-11

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Camber Pharmaceuticals’ generic Bupropion hydrochloride under an ANDA, authorizing a modification to the product’s a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)